These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 22828596

  • 1. Successful treatment of renal artery thromboembolism with low-dose prolonged infusion of tissue-typed plasminogen activator in a patient with mitral mechanical heart valve thrombosis under the guidance of multimodality imaging.
    Aykan AÇ, Gürsoy OM, Ozkan M, Yildiz M, Kahveci G, Uslu Z.
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):663-5. PubMed ID: 22828596
    [Abstract] [Full Text] [Related]

  • 2. Brachial embolism from mechanical mitral valve thrombosis: multimodality imaging-guided successful thrombolysis.
    Cerşit S, Bayam E, Gündüz S, Güner A, Özkan M.
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):395-398. PubMed ID: 29406388
    [Abstract] [Full Text] [Related]

  • 3. A case of unusual looking prosthetic mitral valve thrombosis treated with low dose slow infusion tPA.
    Bayar N, Arslan Ş, Köklü E, Kuş G.
    Anadolu Kardiyol Derg; 2014 May; 14(3):297-9. PubMed ID: 24662584
    [No Abstract] [Full Text] [Related]

  • 4. A Case Series of Obstructive Prosthetic Mitral Valve Thrombosis, Successfully Treated with Low-Dose, Slow Infusion Tissue-Type Plasminogen Activator.
    Ari H, Dogan A, Ceviker K, Aksoy F, Arslan A, Varol E.
    J Heart Valve Dis; 2015 May; 24(3):353-9. PubMed ID: 26901912
    [Abstract] [Full Text] [Related]

  • 5. A serial fluoroscopy-guided thrombolytic therapy of a mechanical tricuspid prosthetic valve thrombosis with low-dose and ultra-slow infusion of tissue-type plasminogen activator.
    Kalçık M, Gürsoy OM, Astarcıoğlu MA, Özkan M.
    Turk Kardiyol Dern Ars; 2014 Jul; 42(5):478-81. PubMed ID: 25080958
    [Abstract] [Full Text] [Related]

  • 6. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.
    Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçık M, Oğuz AE, Gündüz S, Astarcioglu MA, Aykan AÇ, Bayram Z, Biteker M, Kaynak E, Kahveci G, Duran NE, Yıldız M.
    Circulation; 2013 Jul 30; 128(5):532-40. PubMed ID: 23812180
    [Abstract] [Full Text] [Related]

  • 7. [The resolution of a mitral valve prosthesis thrombosis with low-dose plasminogen tissue activator and the role of Doppler echocardiographic monitoring].
    Bertoli D, Filorizzo G, Vivaldi F, Petacchi R.
    G Ital Cardiol; 1994 May 30; 24(5):521-5. PubMed ID: 8076730
    [Abstract] [Full Text] [Related]

  • 8. Localized left atrial administration of tPA for the treatment of mechanical mitral valve thrombosis.
    Desai S, Kavinsky C.
    Catheter Cardiovasc Interv; 2008 Aug 01; 72(2):151-5. PubMed ID: 18655116
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intra-atrial tissue plasminogen activator infusion for prosthetic valve thrombosis.
    Seltzer SM, Reed MD, Siwik ES.
    Catheter Cardiovasc Interv; 2006 Jan 01; 67(1):139-41. PubMed ID: 16345053
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful thrombolytic treatment of a bio-prosthetic mitral valve thrombosis in a pregnant woman.
    Uluganyan M, Karaca G, Nurkalem Z.
    Acta Cardiol; 2013 Aug 01; 68(4):446-8. PubMed ID: 24187776
    [Abstract] [Full Text] [Related]

  • 14. A successful case of repeat thrombolysis in prosthetic valve thrombosis.
    Naleem FS, Basavarajaiah S, Aggarwal R.
    J Heart Valve Dis; 2010 Jan 01; 19(1):155-7. PubMed ID: 20329505
    [No Abstract] [Full Text] [Related]

  • 15. Safety of low-dose prolonged infusion of tissue plasminogen activator therapy in patients with thromboembolic events in the intensive care unit.
    Kalkan ME, Yildiz M, Ak HY, Zencirkiran Agus H, Ozsahin Y, Aykan AC, Oksen D.
    Kardiologiia; 2020 Aug 11; 60(7):86-90. PubMed ID: 33155945
    [Abstract] [Full Text] [Related]

  • 16. Local infusion of fibrinolytic agents for acute renal artery thromboembolism: report of ten cases.
    Salam TA, Lumsden AB, Martin LG.
    Ann Vasc Surg; 1993 Jan 11; 7(1):21-6. PubMed ID: 8518115
    [Abstract] [Full Text] [Related]

  • 17. Mechanical cardiac valve thrombosis. Is fibrinolysis justified?
    Roudaut R, Labbe T, Lorient-Roudaut MF, Gosse P, Baudet E, Fontan F, Besse P, Dallocchio M.
    Circulation; 1992 Nov 11; 86(5 Suppl):II8-15. PubMed ID: 1424038
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of severe mechanical mitral valve thrombosis with tissue plasminogen activator in a 7-month-old infant.
    Cheung EW, Aponte-Patel L, Bacha EA, Singh RK, Rosenzweig EB, Sen AI.
    Pediatr Cardiol; 2013 Nov 11; 34(8):1903-7. PubMed ID: 22886363
    [Abstract] [Full Text] [Related]

  • 19. Successful management of acute renal artery thromboembolism by intra-arterial thrombolytic therapy with recombinant tissue plasminogen activator.
    Cheng BC, Ko SF, Chuang FR, Lee CH, Chen JB, Hsu KT.
    Ren Fail; 2003 Jul 11; 25(4):665-70. PubMed ID: 12911173
    [Abstract] [Full Text] [Related]

  • 20. Obstructive mechanical mitral valve thrombosis and gastric adenocarcinoma: A therapeutic dilemma.
    Karaayvaz E, Demirtakan ZG, Sonsöz MR, Nalbant A, Buğra Z.
    Turk Kardiyol Dern Ars; 2020 Nov 11; 48(8):775-778. PubMed ID: 33257607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.